ORIGINAL RESEARCH article
Front. Allergy
Sec. Rhinology
EUFOREA Summit in Brussels 2025: Inspiring the future of allergy & respiratory care
Susanne Lau 1
Vibeke Backer 2
Glenis Kathleen Scadding 3
Peter J Barnes 4
Manuel Bernal 5
Xander Bertels 6
Michael Blaiss 7,8
Elena Borzova 9
Marie-Charlotte Brüggen 10
Lars Olaf Cardell 11
Diego Marcelo Conti 7
Marjolein Cornet 12
Eugenio De Corso 13
Ratko Djukanovic 14
Wytske Fokkens 15
Adam T Fox 16
Mina Gaga 17
Philippe Gevaert 18
Peter Gibson 19
Claudia Gray 20
Liam Heaney 21
Enrico Heffler 22
Hans Jürgen Hoffmann 23
Claire Hopkins 24
D. Jackson 25
Milos Jesenak 26
Pål Johansen 27
E. Khaleva 28
Stella Lee 29
Mika J. Mäkelä 30
Erik Melén 31
JOAQUIM MULLOL 32
Antonio Nieto García 33
Ian Pavord 34
A. Peters 35
David Price 36
Santiago Quirce 37
Dermot Ryan 38
Sven Schneider 39
B. Senior 40
C.M.E. Shire 41
Peter Smith 42
T. Teeling 41
J.C. Virchow 43
Valerie Lund 44
U. Wahn 1
P.W. Hellings 45
1. Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin Berlin, Germany., Berlin, Germany
2. Department of Otorhinolaryngology, Head & Neck surgery, and Audiology. Rigshospitalet, Copenhagen University, Denmark., Copenhagen, Denmark
3. Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom. Division of Immunity and Infection, University College, London., London, United Kingdom
4. Royal National Heart and Lung Institute, Imperial College London, London, United Kingdom., London, United Kingdom
5. Hospital Clinic, Barcelona, University of Barcelona, Spain., Barcelona, Spain
6. Scientific Expert Team Members, The European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium., Brussels, Belgium
7. Allergy and Clinical Immunology Research Unit, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium
8. Medical College of Georgia at Augusta University, Augusta, GA, United States., Augusta, United States
9. Dermatology Division, Niigata University Graduate School of Medical and Dental Sciences (Medicine), 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510., Niigata, Japan
10. Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Zurich, Switzerland
11. Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Stockolm, Sweden
12. Department of Otorhinolaryngology, Alrijne Hospital, the Netherlands., Alrijne, Netherlands
13. Otolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy., Rome, Italy
14. Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Southhamptom, United Kingdom
15. Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Amsterdam, Netherlands
16. Children’s Allergy Service, Evelina London Children’s Hospital, London, United Kingdom., London, United Kingdom
17. Hygeia Hospital, Athens, Greece; Section of Pulmonary and Critical Care Medicine., Athens, Greece
18. Upper Respiratory Diseases Research Group, University of Ghent, Belgium., Ghent, Belgium
19. Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia., Newcastle, Australia
20. Division of Allergy, Department of Paediatrics and Child Health, University of Cape Town, Rondebosch, South Africa., Cape Town, South Africa
21. Wellcome-Wolfson Institute for Experimental Medicine, 97 Lisburn Road, Belfast, Northern Ireland, UK. BT9 7BL., Belfast, Ireland
22. IRCCS Humanitas Research Hospital, Rozzano., Rome, Italy
23. Department of Clinical Medicine, University of Aarhus, Denmark., Aarhus, Denmark
24. Department of Rhinology and Skull Base Surgery, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK., London, United Kingdom
25. Guy's Severe Asthma Centre, Guy's and St. Thomas' NHS Foundation Trust, and the School of Immunology and Microbial Sciences, King's College London., London, United Kingdom
26. Department of Pulmonology and Phthisiology, Department of Pediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
27. Department of Dermatology, University of Zurich, Zurich, Switzerland., Zurich, Switzerland
28. Clinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK., Southhamptom, United Kingdom
29. Division of Rhinology and Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA., Baltimore, United States
30. HUS Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Helsinki, Finland
31. Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet and Sachs' Children and Youth Hospital, Stockholm, Sweden., Stockolm, Sweden
32. Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES. Barcelona, Catalonia, Spain., Barcelona, Spain
33. Health Research Institute. Hospital La Fe, Valencia, Spain., Valencia, Spain
34. Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Oxford, United Kingdom
35. Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States., Chicago, United States
36. Observational and Pragmatic Research Institute, Singapore, Singapore., Singapore, Singapore
37. Department of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Madrid, Spain
38. Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom., Edinburg, United Kingdom
39. Department of Otorhinolaryngology, Head and Neck Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria., Vienna, Austria
40. Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, Chapel Hill, NC, USA., Chapel Hill, United States
41. Patient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium., Brussels, Belgium
42. Griffth University, Southport, QLD, Australia., Southport, Australia
43. Department of Pneumology, University of Rostock, Rostock, Germany; Intensive Care Medicine, University of Rostock, Rostock, Germany., Rostock, Germany
44. Royal National Ear, Nose and Eastman Dental Hospital, London, UK., London, United Kingdom
45. Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Belgium., Leuven, Belgium
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
EUFOREA, the European Forum for Research and Education in Allergy and Airways diseases, is an international non-for-profit organization of physicians, patients and other stakeholders committed to the improvement of outcomes for patients suffering from chronic inflammatory respiratory conditions through collaborative research, education and targeted advocacy. In February 2025, EUFOREA hosted its biennial Summit in Brussels, convening expert panels, its Patient Advisory Board, and a range of leadership representatives. This event was pivotal in establishing the research, educational and advocacy priorities for the subsequent two-year period, coinciding with the organisation's tenth anniversary in April 2025. Building on its core competencies, EUFOREA advances evidence-based clinical tools and educational initiatives designed to narrow the gap between emerging science and routine care. In alignment with the objective of enhancing global healthcare standards, the specialists’ panels of chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergic rhinitis (AR), asthma, allergen immunotherapy (AIT) and paediatrics have devised and detailed a comprehensive range of initiatives that address significant unmet needs within the domains of allergy and respiratory care. This document presents a summary of EUFOREA's future objectives, aspirations and strategy, providing a clear direction for the coming years. It serves as a valuable resource for individuals and organisations involved in both the allergy and respiratory sectors, offering a comprehensive overview of the association's plans and initiatives.
Summary
Keywords
allergen immunotherapy, Asthma, COPD, EUFOREA, paediatric allergy, Rhinitis, rhinosinusitis, summit.EUFOREA
Received
13 November 2025
Accepted
26 January 2026
Copyright
© 2026 Lau, Backer, Scadding, Barnes, Bernal, Bertels, Blaiss, Borzova, Brüggen, Cardell, Conti, Cornet, De Corso, Djukanovic, Fokkens, Fox, Gaga, Gevaert, Gibson, Gray, Heaney, Heffler, Hoffmann, Hopkins, Jackson, Jesenak, Johansen, Khaleva, Lee, Mäkelä, Melén, MULLOL, Nieto García, Pavord, Peters, Price, Quirce, Ryan, Schneider, Senior, Shire, Smith, Teeling, Virchow, Lund, Wahn and Hellings. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: P.W. Hellings
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.